UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038516
Receipt number R000043892
Scientific Title Prospective observational study on image quality and diagnostic ability evaluation by glucagon administration during prostate MRI scan
Date of disclosure of the study information 2020/04/01
Last modified on 2019/11/07 20:00:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective observational study on image quality and diagnostic ability evaluation by glucagon administration during prostate MRI scan

Acronym

Glucagon administration test at prostate MRI scan

Scientific Title

Prospective observational study on image quality and diagnostic ability evaluation by glucagon administration during prostate MRI scan

Scientific Title:Acronym

Glucagon administration test at prostate MRI scan

Region

Japan


Condition

Condition

Prostate cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objective is to evaluate objectively and subjectively whether glucagon used as a pre-medication during prostate MRI imaging contributes to improving image quality and diagnostic ability.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

It is an objective index (quantitative) for image quality evaluation, and performs SNR (signal-to-noise ratio) evaluation.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

Glucagon administration

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <

Age-upper limit

80 years-old >=

Gender

Male

Key inclusion criteria

(1) Situation where prostate cancer or prostate cancer is suspected
(2) Regardless of stage or stage when prostate cancer is diagnosed
(3) Up to 80 years old
(4) Male

Key exclusion criteria

Excluded if consent to this study is not obtained.

Target sample size

65


Research contact person

Name of lead principal investigator

1st name Naoko
Middle name
Last name Mori

Organization

Tohoku University

Division name

Diagnostic Radiology

Zip code

9808574

Address

1-1, Seiryo-cho, Aoba-ku, Sendai

TEL

0227177312

Email

naokomori7127@gmail.com


Public contact

Name of contact person

1st name Naoko
Middle name
Last name Mori

Organization

Tohoku University

Division name

Diagnostic Radiology

Zip code

9808574

Address

1-1, Seiryo-cho, Aoba-ku, Sendai

TEL

0227177312

Homepage URL


Email

naokomori7127@gmail.com


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Tohoku University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tohoku University

Address

1-1, Seiryo-cho, Aoba-ku, Sendai

Tel

022-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 11 Month 07 Day

Date of IRB


Anticipated trial start date

2019 Year 12 Month 01 Day

Last follow-up date

2021 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 11 Month 07 Day

Last modified on

2019 Year 11 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043892


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name